Population-specific associations with lipid traits have been reported for PCSK9 [32] while its genetic variants, whose effects are thought to be mimicked by PCSK9 inhibitors, are associated with lower LDL cholesterol levels and higher T2D risk[33]. The gene discussed is PCSK9; the disease is type 2 diabetes mellitus.